Aligning Nonclinical, CMC, and Clinical Sections for a Cohesive IND
Introduction A strong IND submission is more than a collection of separate documents. We often see audit and FDA observations […]
FDA Review
Expert Insights: Preparing Your Investigational New Drug Application for FDA Review
Submitting an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) is a defining moment for